The Liver Diseases group of the Vall d'Hebron Research Institute (VHIR) and the Liver and Digestive Diseases area of ​​the CIBER (group CB06/04/0007), led by Dr. Joan Genescà, had a prominent participation in the Liver Seminars 2025, held in Barcelona on June 10 and 11.

VHIR researchers organized their own session on the morning of June 10, conceived as an internal workspace to share current lines of research with the other experts attending the conference. This space provided valuable scientific feedback to advance the definition of hypotheses, the refinement of experimental models, and the development of new therapeutic approaches.

This event included an institutional welcome from the Hospital and VHIR management, a tour of the hospital facilities and the new research building, as well as a scientific session with presentations of ongoing lines of research on FAR proteins, intervention studies in MetALD, and clinical studies in metabolic liver disease.

The Liver Seminars are an international scientific event focused on translational research in liver diseases. This year, led by Dr. Jordi Gracia-Sancho (IDIBAPS) and Prof. F. Javier Cubero (Complutense University of Madrid), the event received organizational support from the four hosts: Dr. Elisa Pose and Dr. Sergi Guixé-Muntet (Hospital Clínic-IDIBAPS), Dr. Anna Moles (IIBB-CSIC), and Dr. Juan M. Pericàs (VHIR - Vall d'Hebron University Hospital and CIBERehd).

The program featured top-level international speakers such as Prof. Gyongy Szabo (Harvard University, USA), Dr. Adrien Guillot (Charité University Hospital, Germany), Dr. Prakash Ramachandran (University of Edinburgh, UK), and Dr. Donato Inverso (San Raffaele Hospital Research Institute, Italy).

Participation in the Liver Seminars reinforces VHIR's commitment to scientific excellence and collaboration within the international community dedicated to understanding and treating liver diseases.